PS.

NHS South of England Branded Medicines - Tranche A - September 2023

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-03ae6d32014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

38

8 SME

Lots

3

39 awarded

Published

14 Aug 2023

Description

NHS South of England Branded Medicines - Tranche A - September 2023<br/><br/>Offer reference number: CM/PHR/22/5676<br/><br/>CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.<br/><br/>CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Scope

Reference
CM/PHR/22/5676
Commercial tool
Standalone contract
Contract dates
31 Aug 2023 to 31 Aug 2025
Main category
goods
CPV classifications
33600000
Contract locations
UK

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
——price—

Submission & procedure

Procedure
Open procedure

Award details· 39 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
SL
Sandoz Ltd
SME
AL
Amgen Ltd
AL
Accord-UK Ltd
RP
Roche Products Ltd
TU
Teva UK Limited
AL
Abbvie Ltd
PU
Pharmacosmos UK Ltd
SME
PL
Pfizer Ltd
JL
Janssen-Cilag Ltd
MS
Merck Serono Limited
VP
Vifor Pharma UK Ltd
SME
CP
Chugai Pharma UK Ltd
SME
NN
Novo Nordisk
ME
Merz
SME
NP
Napp Pharmaceuticals Ltd
OU
Orifarm UK
CH
Celltrion Healthcare United Kingdom Limited
GU
GlaxoSmithKline UK Limited
TA
Thornton and Ross Ltd
SP
Sun Pharma UK Ltd
AL
Accord-UK Ltd
RP
Roche Products Ltd
MS
Merck Sharpe and Dohme (UK) Limited
TU
Teva UK Limited
AS
AstraZeneca
ZP
Zentiva Pharma UK Ltd
AL
Abbvie Ltd
PL
Pfizer Ltd
AP
Aventis Pharma ltd t/a Sanofi
JL
Janssen-Cilag Ltd
EL
Eli Lilly and Company Ltd
TU
Takeda UK Ltd
OP
Organon Pharmaceuticals UK Ltd
GR
Gedeon Richter UK Ltd
SME
GB
Galapagos Biotech Ltd
SME
NP
Novartis Pharmaceuticals UK Ltd
SO
Sobi (Swedish Orphan Biovitrum Ltd)
SME
UP
UCB Pharma Ltd (primary)

Lots · 3 total

Divisions of the contract. Each lot can be awarded separately.

View all →
LotTitleEst. valueStatus
1CM/PHR/22/5676/01£141.8mcancelled
2CM/PHR/22/5676/02£434.4mcancelled
3CM/PHR/22/5676/03£1cancelled